Search - tctmd.com

Displaying 381 - 400 of 688

Sort: Relevancy | Date

News Daily News

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Caitlin E. Cox

January 25, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Yael L. Maxwell

January 05, 2016

News Daily News

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

Yael L. Maxwell

January 05, 2016

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

$Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?$

Presentation TCT 2015

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel

October 15, 2015

Presentation TCT 2015

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

News Conference News TCT 2015

TCT Remembers Liliana Grinfeld, MD, PhD

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 4 Academia Perspectives

Presenter: Roxana Mehran, Laura Mauri

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 3 Industry Perspectives

Presenter: Roxana Mehran, Keith D. Dawkins

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 2 EMA Perspectives

Presenter: Roxana Mehran, Angeles Alonso Garcia

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 1 FDA Perspectives

Presenter: Roxana Mehran, John C Laschinger

October 13, 2015

Presentation TCT 2015

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

Presenter: Roxana Mehran, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

Presenter: Ajay J. Kirtane, Roxana Mehran, Sanjay Kaul

October 12, 2015

Advertisement

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

TCT Remembers Liliana Grinfeld, MD, PhD

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

Big Data: Opportunities and Challenges 4 Academia Perspectives

Big Data: Opportunities and Challenges 3 Industry Perspectives

Big Data: Opportunities and Challenges 2 EMA Perspectives

Big Data: Opportunities and Challenges 1 FDA Perspectives

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content